Allscripts announces first quarter 2018 results
May 03, 2018 20:02 pm UTC| Business
Reported first quarter growth of 24% in GAAP revenue to $514 million, 25% in non-GAAP revenue to $519 million; First quarter GAAP EPS of ($0.22) reflecting acquisition transaction fees, growth of 23% in non-GAAP EPS to...
AveXis Reports First Quarter 2018 Financial and Operating Results
May 03, 2018 20:02 pm UTC| Business
-- Significant progress across operating functions including licensing, clinical trials and regulatory interactions -- -- AVXS-101 pre-BLA meeting with FDA is scheduled to be held in June 2018 -- CHICAGO, May 03, 2018 ...
Stericycle, Inc. Reports Results for the First Quarter 2018
May 03, 2018 20:02 pm UTC| Business
LAKE FOREST, Ill., May 03, 2018 -- Stericycle, Inc. (Nasdaq:SRCL) today reported results for the first quarter ended March 31, 2018. FIRST-QUARTER HIGHLIGHTS COMPARED TO PRIOR YEAR: Revenues of $895.0 million, an...
CRISPR Therapeutics to Participate in May Investor Conferences
May 03, 2018 20:02 pm UTC| Business
ZUG,SwitzerlandandCAMBRIDGE, Mass., May 03, 2018 -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that...
May 03, 2018 20:02 pm UTC| Business
-- First quarter 2017 EXONDYS 51® (eteplirsen) total net revenues of $64.6 million -- -- Sarepta signs exclusive partnership and buy-out option with Myonexus Therapeutics; pipeline expands from 16 to 21 programs -- --...
Apricus Biosciences Provides Corporate Update and First Quarter 2018 Financial Results
May 03, 2018 20:02 pm UTC| Business
SAN DIEGO, May 03, 2018 -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company seeking to advance innovative medicines in urology and rheumatology, today reported financial results for the first quarter...
May 03, 2018 20:01 pm UTC| Business
LIVONIA, Mich., May 03, 2018 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including...